Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Gordon

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
The American Journal of Pathology|September 30, 2005
Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding siteT Sakari Jokiranta, Zhu-Zhu Cheng, Harald Seeberger, et al.
The Journal of General Virology|January 7, 2021
Changes in complement alternative pathway components, factor B and factor H during dengue virus infection in the AG129 mouseSheila Cabezas-Falcon, Aidan J Norbury, Jarrod Hulme-Jones, et al.
Vaccine|May 28, 2021
Protective role of PhtD and its amino and carboxyl fragments against pneumococcal sepsisGreiciely O André, Mayara T Borges, Lucas Assoni, et al.
Ebiomedicine|March 24, 2017
The Pneumococcal Alpha-Glycerophosphate Oxidase Enhances Nasopharyngeal Colonization through Binding to Host GlycoconjugatesLayla K Mahdi, Melanie A Higgins, Christopher J Day, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 10, 2005
Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoproteinJennifer L McRae, Thomas G Duthy, Kim M Griggs, et al.
Msphere|April 20, 2018
Impact of Long-Term Erythromycin Therapy on the Oropharyngeal Microbiome and Resistance Gene Reservoir in Non-Cystic Fibrosis BronchiectasisJocelyn M Choo, Guy C J Abell, Rachel Thomson, et al.
Plos One|October 22, 2015
Use of an Innovative Personality-Mindset Profiling Tool to Guide Culture-Change Strategies among Different Healthcare Worker GroupsM Lindsay Grayson, Nenad Macesic, G Khai Huang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2008
Emergence of coagulase-negative staphylococci as a cause of native valve endocarditisVivian H Chu, Christopher W Woods, Jose M Miro, et al.
The Lancet. Infectious Diseases|September 18, 2020
Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trialGuy de Bruyn, David L Gordon, Theodore Steiner, et al.
Nature Communications|February 20, 2021
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19Adam K Wheatley, Jennifer A Juno, Jing J Wang, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
The American Journal of Pathology|September 30, 2005
Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding siteT Sakari Jokiranta, Zhu-Zhu Cheng, Harald Seeberger, et al.
The Journal of General Virology|January 7, 2021
Changes in complement alternative pathway components, factor B and factor H during dengue virus infection in the AG129 mouseSheila Cabezas-Falcon, Aidan J Norbury, Jarrod Hulme-Jones, et al.
Vaccine|May 28, 2021
Protective role of PhtD and its amino and carboxyl fragments against pneumococcal sepsisGreiciely O André, Mayara T Borges, Lucas Assoni, et al.
Ebiomedicine|March 24, 2017
The Pneumococcal Alpha-Glycerophosphate Oxidase Enhances Nasopharyngeal Colonization through Binding to Host GlycoconjugatesLayla K Mahdi, Melanie A Higgins, Christopher J Day, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 10, 2005
Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoproteinJennifer L McRae, Thomas G Duthy, Kim M Griggs, et al.
Msphere|April 20, 2018
Impact of Long-Term Erythromycin Therapy on the Oropharyngeal Microbiome and Resistance Gene Reservoir in Non-Cystic Fibrosis BronchiectasisJocelyn M Choo, Guy C J Abell, Rachel Thomson, et al.
Plos One|October 22, 2015
Use of an Innovative Personality-Mindset Profiling Tool to Guide Culture-Change Strategies among Different Healthcare Worker GroupsM Lindsay Grayson, Nenad Macesic, G Khai Huang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2008
Emergence of coagulase-negative staphylococci as a cause of native valve endocarditisVivian H Chu, Christopher W Woods, Jose M Miro, et al.
The Lancet. Infectious Diseases|September 18, 2020
Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trialGuy de Bruyn, David L Gordon, Theodore Steiner, et al.
Nature Communications|February 20, 2021
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19Adam K Wheatley, Jennifer A Juno, Jing J Wang, et al.
Pageof 8